Jeff E. Cobb

Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662

Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe et al. · Biochemistry · 2002 · 561 citations

Medicine, Medicinal Chemistry, Pharmacology +17

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen et al. · Journal of Medicinal Chemistry · 1998 · 301 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Early metabolic markers identify potential targets for the prevention of type 2 diabetes

Jeff E. Cobb, Loïc Yengo, Philippe Froguel et al. · Diabetologia · 2017 · 141 citations · Full text

Life Sciences, Biochemistry, Biostatistics +17

α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance

Jeff E. Cobb, Andrea D. Eckhart, Alison A. Motsinger‐Reif et al. · Diabetes Care · 2016 · 131 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the <i>N</i>-Aryl Substituent

Jeff E. Cobb, Steven G. Blanchard, Evan G. Boswell et al. · Journal of Medicinal Chemistry · 1998 · 111 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14